FDA Inspection 855866 — Lincare Inc
The FDA completed an inspection of Lincare Inc on Nov 20, 2013 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 20, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint Paul, MN (United States)